Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 445

Mike Murray on watching for the changing narrative

Mike Murray is Head of Domestic Equities at Australian Ethical, which manages over $6 billion in Australian equities and multi-asset funds. Australian Ethical has launched its first ETF, the High Conviction Fund (ticker: AEAE).


GH: After a long history of funds in the unlisted space, what has motivated the launch of an active ETF and why this particular fund?

MM: There’s been a huge growth in demand for ethical investments and people want something that's true to label and ultimately it needs to be accessible. That’s where the ETF comes in. It’s a good product in terms of the ease of use and not having to fill out all the paperwork that typically goes with a managed fund. And while there have been a lot of fund launches in the sustainability space, there aren't a lot of true domestic ethical active managers in the ETF space. So we thought there was a bit of a gap there.

GH: You've chosen the High Conviction version, what was behind that?

MM: High Conviction means a more concentrated strategy than some of our other strategies. It aligns with our ethical charter and active management, looking for sustainable business models but it also plays a bit higher up the market capitalisation curve. It holds some small caps but it is a bit more overweight some of the mid caps and larger cap stocks, and that gives it a bit more dividend yield. It's not really reinventing the wheel. It's an extension of what we're already doing.

GH: What will be the maximum weighting allowed in any one stock?

MM: Up to 10% in an individual name but that's unlikely in practice, we'd expect 5% to 7% would be a typical position for a larger capitalisation stock.

GH: ESG and sustainable investing is pretty much mainstream now, you hardly find a fund manager who doesn't claim to operate under these principles. How does Australian Ethical maintain a point of difference?

MM: It’s a good thing that it’s mainstream, but we've got an ethical charter that's really unchanged for 30 years, and we only do one thing. Probably a slightly more nuanced point is that we don't think ethical investing is exactly the same as ESG. Ethical investment goes deeper, it's more about values, aligning the portfolio with the values of the client. We think some things have inherent value, creating a positive impact on people, the planet and animals. Those things have inherent value that we can't necessarily measure in risk and return.

GH: You've been at Australian Ethical since 2016. What's been your best investment decision over that time?

MM: A company that's done very well in the last five years is Fisher & Paykel Healthcare, a very innovative company and that's one of the keys to their success. They had a core technology relating to humidification of ventilated air in hospitals and so they benefited from making a positive impact in the COVID setting. They moved into CPAP and the nasal high flow, which is a type of oxygen therapy. The share price over five or six years has gone from $10 to $30. We're not actively adding to the position but we like the management, its organic growth profile and the business model.

GH: And on the other side of the ledger, is there a stock that you sold recently that's made you think about your investment process and how you analyse investments?

MM: Well, not a company that we've sold recently but it's under takeover. One that hasn't gone according to plan is Australian Pharmaceutical Industries, API, the pharmaceutical wholesaler and they also own the Priceline franchise business. We believed in the Priceline footprint and the company met our ethical hurdles as well. But shortly after investing in the company, the management changed and became more focused on acquisitions rather than organic growth, some outside their core competency. It hasn't really delivered in terms of earnings. The lesson is to watch for changing narratives in companies when you're meeting with them. When a company starts acquiring outside its core, sometimes it tells you something about their core business and the growth profile.

A slightly more nuanced thing is that we have done much better at product-oriented companies than service- oriented companies. A case in point is aged care, which was a hot sector for a while but it hasn't really delivered, it hasn't scaled, and we think product-oriented businesses scale better than personal services.

GH: Do you own a stock that you expect to keep for a long time, maybe 10 years?

MM: We are very patient providers of capital but when you're a fund manager, a lot of things change in 10 years, you might even see two or three CEOs. You can see companies get very overvalued or very undervalued in that period and if a company becomes very overvalued, we would sell it. Cochlear is another company we've held for a long time, it's a market leader and the business does tremendous social good and their markets are under penetrated. They've got a high gross margin. They probably raised too much capital during COVID which was very conservative as business bounced back much quicker than people expected. They’ve ended up with $500 million of cash on the balance sheets, they’re conservatively geared. So you pay a high PE but over a 10-year period that will come down, given the strong growth rate.

GH: And a good business to own for the previous 10 years as well. Can I delve into your ethical process a bit more? When you're assessing a stock like Coles or Woolworths, which both sell tobacco, alcohol, sugary products, which are on the negative side of the ethical ledger. How would you weigh up owning a stock like that?

MM: That’s a really good question. We distinguish between companies that are direct producers of some of those harmful products … and we do think they’re harmful, there’s no real debate about that. In this case, they are retailers, we would not classify them as direct producers, they are indirect participants in those markets. The second part is: are they selling more than their natural share of those products and are they strategically involved in those industries? We don’t think those companies have an overweighting in those areas.

And then we ask if there are other positives in the business, and we think the answer is yes. Both those businesses are important in the overall economy. Coles is held in the High Conviction strategy and is committed to 100% renewables by 2025. They are signatories to the alcohol beverage advertising code, we can see quite a lot of positives. None of these companies is perfect so we're always making these judgements.

GH: Do you own any stocks now which may not have passed your ethical screens, say five years ago?

MM: We’ve seen both sides. We no longer invest in Tasmanian salmon producers for ethical reasons. But on the other hand, a company like Downer moved out of the mining contracting space into more of a light footprint, urban contracting business with a big role to play in energy transition. In building, there is a commitment from some businesses to a lower footprint and newer technologies, such as Fletcher Building and Boral. And in other cases, the end use of a product has changed, such as with lithium. Traditionally, we would not invest in mining companies but they are important for batteries and decarbonisation.

GH: Finally, any new developments at Australian Ethical coming this year?

MM: There's enough going on in the field of ethical investment to keep us occupied. You should expect us to stick to our knitting. We don't have a big presence in active international equities at the moment. That's something with some very interesting technology addressing society's problems. And more ETFs as we look across our product suite, they are on the radar.


Graham Hand is Managing Editor of Firstlinks. Michael Murray is Head of Domestic Equities at Australian Ethical, a sponsor of Firstlinks. This information is of a general nature and is not intended to provide you with financial advice or take into account your personal objectives, financial situation or needs.

For more articles and papers from Australian Ethical, please click here.



Sustainable, responsible or ethical – what’s the difference?

The best income-generating assets for your portfolio

Arms stocks don’t belong in our ESG funds


Most viewed in recent weeks

16 ASX stocks to buy and hold forever

In his recent shareholder letter, Warren Buffett mentions several stocks he expects Berkshire Hathaway will own indefinitely, including Occidental Petroleum. We look at ASX stocks that investors could buy and hold forever.

The best strategy to build income for life

Owning quality, dividend-producing industrial shares is key to building a decent income stream. Here is an update on the long-term performance of industrial stocks against indices, listed property, and term deposits.

Are more taxes on super on the cards?

The Government's broken promise on tax cuts has prompted speculation about other promises that it may consider breaking. It's widely believed that super is lightly taxed and a prime candidate for special attention.

Lessons from the battery metals bust

The crash in lithium and nickel prices has left companies scrambling to cut production, billionaires red-faced, and investors wondering how a ‘sure thing’ went so wrong. There are plenty of lessons for everyone.

Welcome to Firstlinks Edition 545 with weekend update

It’s troubling that practical skills like investing aren’t taught at schools as it leaves our children ill-equipped to build wealth, and more vulnerable to bad advice. Here are some suggestions to address the issue.

  • 1 February 2024

For the younger generation, we need to get real on tax

The distortions in our tax system have been ignored for too long, and we're now paying the price. It's time Australia got real and addressed the problems to prevent an even greater intergenerational tragedy.

Latest Updates


16 ASX stocks to buy and hold forever

In his recent shareholder letter, Warren Buffett mentions several stocks he expects Berkshire Hathaway will own indefinitely, including Occidental Petroleum. We look at ASX stocks that investors could buy and hold forever.

Investment strategies

Clime time: 10 charts on the outlook for major asset classes

The charts reveal that interest rates can't rise much further as Australian mortgage holders are under stress, bank dividends look solid, and the bond market is in flux because yields are being manipulated.


Phasing out cheques, and what will happen to cash?

Cheques and bank service, or the lack of, were major topics when I addressed a seniors’ group recently. The word had got out that the government was phasing out cheques, and many in the audience were feeling abandoned.


What financial risks do retirees face?

Treasury's consultation into the retirement phase of superannuation is generating a lot of interest. This submission to the consultation outlines the key financial risks to an individual’s standard of living in retirement.


Recession surprise may be in store for the US stock market

Markets are partying like it's 1999, but history suggests that US earnings and economic growth are vulnerable following an interest rate tightening cycle. Investors should prepare their portfolios accordingly.

Investment strategies

3 under the radar investment opportunities

The Magnificent Seven are hogging the headlines, yet there are plenty of growth opportunities elsewhere, at a fraction of the cost. Here are three stock ideas riding key areas of structural and cyclical change.


Why a quant approach can thrive in the age of passive investing

The rise of passive investing is unlikely to derail the value of quantitative strategies. Passive investing hasn’t eradicated the irrationality of crowds, leaving pockets of opportunity to outperform indices.



© 2024 Morningstar, Inc. All rights reserved.

The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.